The research team is part of the Primary Immune Deficiency Treatment Consortium, which has 44 centres across North America. Funded by the National Institute of Allergy and Infectious Diseases (NIAID), the consortium aims to improve the treatment of immune deficiencies and accelerate the transfer of knowledge to the clinic. Dr. Haddad sits on the consortium’s steering committee and is co-author of the specific research protocol for SCID.
MD, PhD Elie Haddad
Professor of Pediatrics, Head Division CHU Ste-Justine, University of Montreal
About MD, PhD Elie Haddad
Talks and events
Follow Elie Haddad participation during the meeting